Select Medical Holdings Corp has a consensus price target of $36.13 based on the ratings of 8 analysts. The high is $48 issued by Benchmark on July 16, 2024. The low is $26 issued by UBS on November 30, 2023. The 3 most-recent analyst ratings were released by Benchmark, RBC Capital, and Benchmark on July 16, 2024, May 6, 2024, and May 6, 2024, respectively. With an average price target of $43.33 between Benchmark, RBC Capital, and Benchmark, there's an implied 12.35% upside for Select Medical Holdings Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/16/2024 | Buy Now | 24.45% | Benchmark | Bill Sutherland | $42 → $48 | Maintains | Buy | Get Alert |
05/06/2024 | Buy Now | 3.71% | RBC Capital | Ben Hendrix | $36 → $40 | Maintains | Outperform | Get Alert |
05/06/2024 | Buy Now | 8.89% | Benchmark | Bill Sutherland | $39 → $42 | Maintains | Buy | Get Alert |
05/03/2024 | Buy Now | 1.11% | Benchmark | Bill Sutherland | → $39 | Reiterates | Buy → Buy | Get Alert |
04/12/2024 | Buy Now | 1.11% | Benchmark | Bill Sutherland | → $39 | Reiterates | Buy → Buy | Get Alert |
11/30/2023 | Buy Now | -32.59% | UBS | A.J. Rice | → $26 | Initiates | → Neutral | Get Alert |
11/08/2023 | Buy Now | 1.11% | Benchmark | Bill Sutherland | → $39 | Reiterates | Buy → Buy | Get Alert |
08/07/2023 | Buy Now | -17.03% | Credit Suisse | Jonathan Yong | $29 → $32 | Maintains | Neutral | Get Alert |
07/20/2023 | Buy Now | -1.48% | RBC Capital | Ben Hendrix | → $38 | Reiterates | Outperform → Outperform | Get Alert |
05/08/2023 | Buy Now | -1.48% | RBC Capital | Ben Hendrix | $32 → $38 | Maintains | Outperform | Get Alert |
05/08/2023 | Buy Now | -24.81% | Credit Suisse | Jonathan Yong | → $29 | Reiterates | → Neutral | Get Alert |
02/27/2023 | Buy Now | 1.11% | Benchmark | Bill Sutherland | → $39 | Reiterates | → Buy | Get Alert |
02/27/2023 | Buy Now | -24.81% | Credit Suisse | Jonathan Yong | $24 → $29 | Maintains | Neutral | Get Alert |
11/07/2022 | Buy Now | -17.03% | RBC Capital | Ben Hendrix | $36 → $32 | Maintains | Outperform | Get Alert |
05/17/2022 | Buy Now | -30% | Credit Suisse | Nick Giovacchini | $28 → $27 | Maintains | Neutral | Get Alert |
05/10/2022 | Buy Now | -6.66% | RBC Capital | Ben Hendrix | $42 → $36 | Maintains | Outperform | Get Alert |
03/16/2022 | Buy Now | -27.4% | Credit Suisse | Nick Giovacchini | $37 → $28 | Maintains | Neutral | Get Alert |
03/07/2022 | Buy Now | 8.89% | RBC Capital | Frank Morgan | $47 → $42 | Maintains | Outperform | Get Alert |
01/18/2022 | Buy Now | -9.26% | B of A Securities | Kevin Fischbeck | $40 → $35 | Maintains | Buy | Get Alert |
01/18/2022 | Buy Now | 21.86% | RBC Capital | Ben Hendrix | $50 → $47 | Maintains | Outperform | Get Alert |
08/10/2021 | Buy Now | 1.11% | Credit Suisse | — | — | Maintains | Neutral | Get Alert |
The latest price target for Select Medical Hldgs (NYSE:SEM) was reported by Benchmark on July 16, 2024. The analyst firm set a price target for $48.00 expecting SEM to rise to within 12 months (a possible 24.45% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Select Medical Hldgs (NYSE:SEM) was provided by Benchmark, and Select Medical Hldgs maintained their buy rating.
There is no last upgrade for Select Medical Hldgs
There is no last downgrade for Select Medical Hldgs.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Select Medical Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Select Medical Hldgs was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
While ratings are subjective and will change, the latest Select Medical Hldgs (SEM) rating was a maintained with a price target of $42.00 to $48.00. The current price Select Medical Hldgs (SEM) is trading at is $38.57, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.